In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CFR Pharmaceuticals SA

Division of Abbott Laboratories Inc.
www.cfr-corp.com

Latest From CFR Pharmaceuticals SA

JPM15: Abbott Eyes Emerging Markets Only For Branded Generics Biz

Just in case the sight of Abbott divesting its branded generics businesses in developed markets to Mylan was not a clear enough signal of the company’s intention to focus solely on emerging markets, Michael J. Warmuth , the EVP with responsibility for the business, took the opportunity to spell it out at the recent JP Morgan Healthcare conference.

BioPharmaceutical Business Strategies

Emerging Markets Earnings: Abbott Laboratories Casts Fortune Abroad

Emerging markets now account for nearly half of Abbott Laboratories sales – a figure set to grow through regional focus and acquisitions, leading Chicago-based CEO Miles White and other executives to skip over vast portions of the globe in the third quarter earnings call.

BioPharmaceutical Consumer

Emerging Markets Earnings: Abbott Laboratories Casts Fortune Abroad

Emerging markets now account for nearly half of Abbott Laboratories sales – a figure set to grow through regional focus and acquisitions, leading Chicago-based CEO Miles White and other executives to skip over vast portions of the globe in the third quarter earnings call.

BioPharmaceutical Consumer

Biopharma Dealmaking Quarterly Statistics, Q2 2014

Biopharma financing totaled $7.2 billion, a 36% decrease from Q1; 36 completed M&As had a combined potential value reaching $116 billion, more than three-and-a-half times the previous quarter; 84 biopharma alliances, together totaling $7.7 billion in potential pre-commercialization value, showed a significant jump from Q1’s $1.9 billion aggregate.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
    • OTC, Consumer
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • South America
      • Chile
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • Alejandro Weinstein Manieu, CEO
    Patricio Vargas, CFO
  • Contact Info
  • CFR Pharmaceuticals SA
    Phone: 2 2350 5200
    Av. Pedro de Valdivia 295
    ,
    Chile
Advertisement
Advertisement
UsernamePublicRestriction

Register